DIY swab could revolutionize anal cancer screening for HIV patients
NCT ID NCT07438080
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether people living with HIV can accurately collect their own swab samples to screen for HPV, a virus that can lead to anal cancer. Researchers will compare self-swabs to those taken by a doctor and ask participants which method they prefer. If self-screening works well, it could make regular cancer screening easier and more private for this high-risk group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HPV self-test (vaginal self-swab)
What this could lead to
If self-screening proves accurate and acceptable, it could make anal cancer screening easier and more accessible for people with HIV, potentially catching pre-cancers earlier.
What could go wrong
This is a small, early-stage study focused on accuracy and acceptability, not on preventing cancer itself. Self-swabbing may be less accurate than a clinician's swab, and results may not apply to other populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CegiDD Saint Pierre
RECRUITINGSaint-Pierre, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Cegidd Saint Paul
RECRUITINGSaint-Paul, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••